Int J Arrhythm.  2020 Mar;21(1):e3. 10.1186/s42444-020-0011-2.

Differences in anticoagulation strategy and outcome in atrial fibrillation patients with chronic kidney disease: a CODE‑AF registry study

• Choi Y
• Uhm J
• Kim T
• Choi Y
• Uhm J
• Cha M
• Kim T
• Lee J
• Park J
• Park J
• Kang K
• Shim J
• Kim J
• Park H
• Choi E
• Kim J
• Kim C
• Lee Y
• Joung B

• KMID: 2507215
• DOI: http://doi.org/10.1186/s42444-020-0011-2

Abstract

Purpose
Dose reduction of non-vitamin K antagonist oral anticoagulants (NOACs) is indicated in patients with atrial fibrillation (AF) with renal impairment. This study investigated anticoagulation patterns and outcomes in patients with chronic kidney disease (CKD).
Materials and methods
In a prospective observational registry (CODE-AF), 3445 patients with non-valvular AF including 1129 with CKD (estimated glomerular filtration rate ≤ 60 mL min⁻¹ 1.73 m⁻²) were identified between June 1, 2016, and July 3, 2017.
Results
Compared with patients with no-CKD, patients with CKD more frequently had a high stroke risk (94.9% vs. 67.0%, p < 0.001) and higher NOAC usage rate (61.1% vs. 47.8%, p < 0.001). Among 718 patients with renal indication for dose reduction (RIDR), 7.5% were potentially overdosed. Among 2587 patients with no-RIDR, 79% were potentially underdosed. Compared with patients with no-RIDR, the underdose rates of dabigatran (0% vs. 88.6%, p = 0.001) and rivaroxaban (0% vs. 79.5%, p = 0.001) were lower in patients with RIDR. However, the underdose rate of apixaban was not different (62.5% vs. 53.9%, p = 0.089). The overdose rate of dabigatran (7.5% vs. 0%) and rivaroxaban (13.7% vs. 0%) was higher in RIDR than in no-RIDR patients. Stroke/transient ischemic attack was significantly higher in CKD patients (1.4 vs. 0.6 per 100 person-years, p = 0.045). Aspirin significantly increased minor bleeding in CKD patients compared with controls (p = 0.037).
Conclusion
CKD patients might have a high stroke risk and NOAC usage rate. The underdose rate of NOACs decreased in CKD patients, except for apixaban. Aspirin significantly increased minor bleeding in CKD patients.

Keyword

Atrial fibrillation; Anticoagulation; Kidney diseases; Stroke